Clinical Study
Renal Transplantation in Hepatitis C Positive Patients: A Single Centre Experience
Table 1
Demographics of renal transplant HCV-positive patients (group A) and control patients (group B).
| | Patients () | Group A () | Group B () |
| | Mean age (years; ± SD) | | | | Mean donor age (years; ± SD) | | | | Patient gender (male : female) | 122 : 10 | 59 : 20 | | Third-party infusions | | | | HLA match: —in percentage | | | | 0 | 12.1 () | 5.1 () | | 1 | 18.9 () | 7.6 () | | 2 | 25.8 () | 10.1 () | | 3 | 30.3 () | 34.1 () | | 4 | 5.3 () | 8.9 () | | 5 | 1.5 () | 3.8 () | | 6 | 0 | 0 | | Not performed | 6.1 () | 30.4 () | | Basic disease—in percentage | | | | CGN | 50 () | 45.6 () | | DM-DN | 10.6 () | 3.8 () | | CTIN | 14.4 () | 10.1 () | | Obstructive uropathy | 4.6 () | 6.4 () | | ADPKD | 1.5 () | 3.8 () | | Nephrosclerosis | 12.1 () | 16.5 () | | FSGS | 0 | 2.5 () | | Membranous nephropathy | 0.8 () | 2.5 () | | IgA nephropathy | 0 | 1.26 () | | MPGN | 0 | 1.26 () | | Vasculitis | 0.8 () | 0 | | HUS | 0 | 1.26 () | | Lupus nephritis | 2.2 () | 2.5 () | | Alport syndrome | 1.5 () | 1.26 () | | Others | 1.5 () | 1.26 () |
|
|
Abbreviations: ADPKD: autosomal dominant polycystic kidney disease; CGN: chronic glomerulonephritis; CTIN: chronic tubulointerstitial nephritis; DM-DN: diabetes mellitus, diabetic nephropathy; FSGS: focal segmental glomerulosclerosis; HUS: hemolytic uremic syndrome; MMF: mycofenolate mofetil; MN: membranous nephropathy.
|
